Comparative Analysis of Antithrombotic Therapy Outcomes in Mild Traumatic Brain-Injury Patients: A Focus on Bleeding Risk and Hospital-Stay Duration.
Antonio DesaiDana ShifferMauro GiordanoAlice Giotta LuciferoElena GeneraliFrancesco ReggianiMarta CalatroniGabriele SavioliSabino LuzziAntonio VozaPublished in: Life (Basel, Switzerland) (2024)
The results reveal that TBI patients on anticoagulants/antiplatelets had longer hospital stays compared with those on aspirin alone. Notably, VKA was the strongest predictor for an extended LOS. Regarding ICH, patients taking only aspirin were twice as likely to experience bleeding compared with those on anticoagulants/antiplatelets. However, to achieve statistically significant evidence, further research with a larger cohort of patients is needed.
Keyphrases
- end stage renal disease
- ejection fraction
- newly diagnosed
- healthcare
- peritoneal dialysis
- prognostic factors
- low dose
- emergency department
- traumatic brain injury
- type diabetes
- patient reported outcomes
- metabolic syndrome
- mesenchymal stem cells
- dna methylation
- bone marrow
- mild traumatic brain injury
- percutaneous coronary intervention
- cell therapy
- adverse drug
- antiplatelet therapy